Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: P53 with arginine at codon 72 favors apoptosis

FASEB Journal

Volumn 24, Issue 5, 2010, Pages 1347-1353

  Jeong, Byeong Seon ^a   Hu, Wenwei ^a   Belyi, Vladimir ^b   Rabadan, Raul ^c   Levine, Arnold J ^a,b  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b INSTITUTE FOR ADVANCED STUDY   (United States)

^c Columbia University ^*  (United States)

Author keywords

Single nucleotide polymorphism; Transcription regulation

Indexed keywords

ARGININE; DEATH RECEPTOR 4; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; P53 INDUCIBLE PROTEIN 3; PROLINE; PROTEIN NOXA; PROTEIN P53; PUMA PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ADHESION; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PERP GENE; PRIORITY JOURNAL; GENETIC POLYMORPHISM; GENETICS; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; ARGININE; CELL LINE, TUMOR; CODON; GENE EXPRESSION REGULATION; HUMANS; POLYMORPHISM, GENETIC; PROLINE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77952301694     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-146001     Document Type: Article

References (43)

1. Levine, A. J., Feng, Z., Mak, T. W., You, H., and Jin, S. (2006) Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev. 20, 267-275
2. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331
3. Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., and Vousden, K. H. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107-120
4. Matoba, S., Kang, J. G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., and Hwang, P. M. (2006) p53 regulates mitochondrial respiration. Science 312, 1650-1653
5. Feng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., and Levine, A. J. (2007) The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 67, 3043-3053
6. Feng, Z., Zhang, H., Levine, A. J., and Jin, S. (2005) The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. U. S. A. 102, 8204-8209
7. Yu, X., Harris, S. L., and Levine, A. J. (2006) The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 66, 4795-4801
8. Komarova, E. A., Diatchenko, L., Rokhlin, O. W., Hill, J. E., Wang, Z. J., Krivokrysenko, V. I., Feinstein, E., and Gudkov, A. V. (1998) Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53. Oncogene 17, 1089-1096
9. Adimoolam, S., and Ford, J. M. (2002) p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc. Natl. Acad. Sci. U. S. A. 99, 12985-12990
10. Harris, S. L., and Levine, A. J. (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24, 2899-2908
11. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245
12. Bond, G. L., Hu, W., and Levine, A. J. (2005) MDM2 is a central node in the p53 pathway: 12 years and counting. Curr. Cancer Drug Targets 5, 3-8
13. Batchelor, E., Mock, C. S., Bhan, I., Loewer, A., and Lahav, G. (2008) Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. Mol. Cell 30, 277-289
14. Gottlieb, E., Haffner, R., King, A., Asher, G., Gruss, P., Lonai, P., and Oren, M. and tissue-dependent changes in radiation-induced activation during embryogenesis. EMBO J. 16, 1381-1390
15. Venkatachalam, S., Shi, Y. P., Jones, S. N., Vogel, H., Bradley, A., Pinkel, D., and Donehower, L. A. (1998) Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J. 17, 4657-4667
16. Strong, L. C. (2003) General keynote: hereditary cancer: lessons from Li-Fraumeni syndrome. Gynecol. Oncol. 88, S4-S7; discussion S11-S13
17. Bond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., Bargonetti, J., Bartel, F., Taubert, H., Wuerl, P., Onel, K., Yip, L., Hwang, S. J., Strong, L. C., Lozano, G., and Levine, A. J. (2004) A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119, 591-602
18. Hu, W., Feng, Z., Ma, L., Wagner, J., Rice, J. J., Stolovitzky, G., and Levine, A. J. (2007) A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells. Cancer Res. 67, 2757-2765
19. Murphy, M. E. (2006) Polymorphic variants in the p53 pathway. Cell Death Differ. 13, 916-920
20. Beckman, G., Birgander, R., Sjalander, A., Saha, N., Holmberg, P. A, Kivelä, A., and Beckman, L. (1994) Is p53 polymorphism maintained by natural selection? Hum. Hered. 44, 266-270 (Pubitemid 24229554)
21. Hu, W., Feng, Z., Teresky, A. K., and Levine, A. J. (2007) p53 regulates maternal reproduction through LIF. Nature 450, 721-724
22. Hu, W., Feng, Z., Atwal, G. S., and Levine, A. J. (2008) p53: a new player in reproduction. Cell Cycle 7, 848-852
23. Kay, C., Jeyendran, R. S., and Coulam, C. B. (2006) p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure. Reprod. Biomed. Online 13, 492-496 (Pubitemid 44548783)
24. Kang H., Feng Z., Sun Y., Atwal, G., Murphy, M. E., Rebbeck, T. R., Rosenwaks, Z., Levine, A. J., and Hu, W. (2009) Single nucleotide polymorphisms in the p53 pathway regulate fertility in humans. Proc. Natl. Acad. Sci. U. S. A. 106, 9761-9766
25. Shi H., Tan S., Zhong H., Hu, W., Levine, A., Xiao, C. J., Peng, Y., Qi, X. B., Shou, W. H., Ma, R. L., Li, Y., Su, B., and Lu, X. (2009) Winter temperature and UV affect the genetics of the p53 tumor suppressor pathway in Eastern Asia. Am. J. Hum. Genet. 84, 534-541
26. Wu, X., Zhao, H., Amos, C. I., Shete, S., Makan, N., Hong, W. K., Kadlubar, F. F., and Spitz, M. R. (2002) p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J. Natl. Cancer Inst. 94, 681-690 (Pubitemid 34552489)
27. Sjalander, A., Birgander, R., Hallmans, G., Cajander, S., Lenner, P., Athlin, L., Beckman, G., and Beckman, L. (1996) p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17, 1313-1316
28. Granja, F., Morari, J., Morari, E. C., Correa, L. A., Assumpcao, L. V., and Ward, L. S. (2004) Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett. 210, 151-157
29. Weston, A., Ling-Cawley, H. M., Caporaso, N. E., Bowman, E. D., Hoover, R. N., Trump, B. F., and Harris, C. C. (1994) Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis 15, 583-587 (Pubitemid 24124397)
30. Birgander, R., Sjalander, A., Rannug, A., Alexandrie, A. K., Sundberg, M. I., Seidegård, J., Tornling, G., Beckman, G., and Beckman, L. (1995) P53 polymorphisms and haplotypes in lung cancer. Carcinogenesis 16, 2233-2236
31. Orsted, D. D., Bojesen, S. E., Tybjaerg-Hansen, A., and Nordestgaard, B. G. (2007) Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population. J. Exp. Med. 204, 1295-1301
32. Van Heemst, D., Mooijaart, S. P., Beekman, M., Schreuder, J., de Craen, A. J., Brandt, B. W., Slagboom, P. E., and Westendorp, R. G.; Long Life Study Group. (2005) Variation in the human TP53 gene affects old age survival and cancer mortality. Exp. Gerontol. 40, 11-15
33. Zhang, X., Miao, X., Guo, Y., Tan, W., Zhou, Y., Sun, T., Wang, Y., and Lin, D. (2006) Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Hum. Mutat. 27, 110-117
34. Dumont, P., Leu, J. I., Della Pietra, A. C., 3rd, George, D. L., and Murphy, M. (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 33, 357-365
35. Sullivan, A., Syed, N., Gasco, M., Bergamaschi, D., Trigiante, G., Attard, M., Hiller, L., Farrell, P. J., Smith, P., Lu, X., and Crook, T. (2004) Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 23, 3328-3337
36. Pim, D., and Banks, L. (2004) p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int. J. Cancer 108, 196-199
37. Salvioli, S., Bonafe, M., Barbi, C., Storci, G., Trapassi, C., Tocco, F., Gravina, S., Rossi, M., Tiberi, L., Mondello, C., Monti, D., and Franceschi, C. (2005) p53 codon 72 alleles influence the response to anticancer drugs in cells from aged people by regulating the cell cycle inhibitor p21WAF1. Cell Cycle 4, 1264-1271
38. Attardi, L. D., Reczek, E. E., Cosmas, C., Demicco, E. G., McCurrach, M. E., Lowe, S. W., and Jacks, T. (2000) PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 14, 704-718 (Pubitemid 30176824)
39. Erlacher, M., Michalak, E. M., Kelly, P. N., Labi, V., Niederegger, H., Coultas, L., Adams, J. M., Strasser, A., and Villunger, A. (2005) BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 106, 4131-4138
40. Yu X., Riley T,. and Levine, A. J. (2009) The regulation of the endosomal compartment by p53 the tumor suppressor gene. FEBS J. 276, 2201-2212
41. Ihrie, R. A., and Attardi, L. D. (2005) A new Perp in the lineup: linking p63 and desmosomal adhesion. Cell Cycle 4, 873-876
42. Walker, K. K., and Levine, A. J. (1996) Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl. Acad. Sci. U. S. A. 93, 15335-15340
43. Bergamaschi, D., Samuels, Y., Sullivan, A., Zvelebil, M., Breyssens, H., Bisso, A., Del Sal, G., Syed, N., Smith, P., Gasco, M., Crook, T., and Lu, X. (2006) iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat. Genet. 38, 1133-1141